Biosimilar humira cost?

Prices vary a lot by country, insurer, dosage, and which biosimilar you’re considering. There isn’t a single “Humira biosimilar price.” Here’s the general picture:

- Biosimilars to Humira (adalimumab) are usually priced lower than the originator, often by roughly 10–50% depending on the market and contract.
- In the United States, the list price for adalimumab biosimilars is typically lower than Humira’s, but the exact monthly cost depends on your insurance plan, copays, and any manufacturer discounts or patient-assistance programs. Without insurance, list prices can be in the several-thousand-dollar-per-month range; with insurance, many patients pay far less (sometimes hundreds or less per month, or even near $0 for some plans).
- In other countries with national pricing or negotiated rebates, the savings can be larger and the out-of-pocket cost often much lower.

If you want country-specific numbers or a closer estimate:
- Tell me your country (and whether you have insurance, Medicare/Part D, or a specific plan).
- I can give current typical list prices and explain what a likely out-of-pocket might look like for you.
- I can also help you compare options (different biosimilars) and point you to patient-assistance programs or coupons that might reduce your cost.

Would you like a country-specific price range and steps to check your exact out-of-pocket cost?